- Etiologic Index - A Case-Only Measure of BRCA1/2-Associated Cancer Risk.
- Hughley R, Karlic R, Joshi H, Turnbull C, Foulkes WD, Polak P.
- N Engl J Med. 2020 Jul 16;383(3):286-288. doi: 10.1056/NEJMc1913988.
- PMID: 32668122
- PubMed abstract
- Source abstract
- Letter
- A Novel Mechanism to Induce BRCAness in Cancer Cells.
- Cai C.
- Cancer Res. 2020 Jul 15;80(14):2977-2978. doi: 10.1158/0008-5472.CAN-20-1451.
- PMID: 32193285
- PubMed abstract
- Source abstract
- Commentary
Original research:
Inactivation of the prolyl isomerase Pin1 sensitizes BRCA1-proficient breast cancer to PARP inhibition.
- PMID: 32193285
- PubMed abstract
- Source abstract
- A Phase I/II Study of Veliparib (ABT-888) in combination with 5-Fluorouracil and Oxaliplatin in Patients with Metastatic Pancreatic Cancer.
- Pishvaian MJ, Wang H, He AR, Hwang JJ, Smaglo BG, Kim SS, Weinberg BA, Weiner LM, Marshall JL, Brody JR.
- Clin Cancer Res. 2020 Jul 15:clincanres.1301.2020. doi: 10.1158/1078-0432.CCR-20-1301. Epub ahead of print.
- PMID: 32669374
- PubMed abstract
- Source abstract
- [A Case Report on the Effectiveness of Olaparib in a Patient with Recurrent Breast Cancer with Human Immunodeficiency Virus Infection].
- Yabe S, Iwamoto N, Inokuchi T, Nara M, Saita C, Onishi M, Goto R, Yonekura R, Ishiba T, Honda Y, Miyamoto H, Aruga T.
- Gan To Kagaku Ryoho. 2020 Jul;47(7):1089-1092. Japanese.
- PMID: 32668858
- PubMed abstract
- Case report. [Article in Japanese.]